Personalized treatment strategies based on smoking history in lung cancer

Abhishek Shankar, MD, All India Institute of Medical Sciences, Delhi, India, comments on the importance of collecting smoking status data in clinical trials, which can help understand the response to immunotherapy among smokers. This information can provide insights into the relationship between smoking status and treatment outcomes. This interview took place at 2025 World Conference on Lung Cancer (WCLC) in Barcelona, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.